Impact of patient's specification on clinical outcome for an I-131 ablation therapy with differentiated thyroid carcinoma.

被引：0
|
作者：
Nakayama, M. [1 ]
Okizaki, A. [1 ]
Sakaguchi, M. [2 ]
Uno, T. [2 ]
Sato, J. [2 ]
Ishitoya, S. [1 ]
机构：
[1] Asahikawa Med Univ, Dept Radiol, Asahikawa, Hokkaido, Japan
[2] Asahikawa Med Univ Hosp, Radiol Technol Sect, Asahikawa, Hokkaido, Japan
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2013年 / 40卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：S353 / S353
页数：1
相关论文
共 50 条
  • [41] Usefulness of Iodine 123 ( I-123 ) in Evaluation of Patients with Differentiated Thyroid Carcinoma before Therapy with Iodine 131 ( I-131 )
    Tsilomeleti, I.
    Koutsouba, T.
    Vonorta, K.
    Kalogeropoulos, K.
    Papoutsis, V.
    Plataniotis, N.
    Stromatia, F.
    Nikolopoulou, M.
    Oros, L.
    Anapliotou, M.
    Prassopoulos, V.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2005, 32 : S240 - S241
  • [42] TREATMENT OF DIFFERENTIATED THYROID-CARCINOMA IN 7 DOGS UTILIZING I-131
    ADAMS, WH
    WALKER, MA
    DANIEL, GB
    PETERSEN, MG
    LEGENDRE, AM
    VETERINARY RADIOLOGY & ULTRASOUND, 1995, 36 (05) : 417 - 424
  • [43] The Value of Pre-Ablative I-131 Scan for Clinical Management in Patients With Differentiated Thyroid Carcinoma
    van der Boom, Trynke
    Zandee, Wouter T.
    Dekkers, Claire C. J.
    van der Horst-schrivers, Anouk N. A.
    Jansen, Liesbeth
    Kruijff, Schelto
    Brouwers, Adrienne H.
    Links, Thera P.
    FRONTIERS IN ENDOCRINOLOGY, 2021, 12
  • [44] Effectiveness of I-131 therapy to ablate the thyroid remnant in 200 patients in the multicenter study differentiated thyroid carcinoma (MSDS).
    Biermann, M
    Pixberg, MK
    Schober, O
    JOURNAL OF NUCLEAR MEDICINE, 2003, 44 (05) : 146P - 146P
  • [45] Salivary glands retention on the I-131 diagnostic WBS for patients with differentiated thyroid carcinoma with a single or multiple I-131 therapies
    Saranti, S.
    Antoniou, D.
    Diamantakis, K.
    Papadouli, D.
    Rethymniotakis, K.
    Moschoyiannis, V.
    Georgakopoulos, A.
    Pateniotis, K.
    Matselas, E.
    Trivizaki, E.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 : S450 - S450
  • [46] Salivary glands retention on the I-131 diagnostic WBS for patients with differentiated thyroid carcinoma with a single or multiple I-131 therapies
    Gaberscek, S.
    Zaletel, K.
    Osolnik, J.
    Bajuk, N. Bedernjak
    Pirnat, E.
    Hojker, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 : S450 - S450
  • [47] Clinical usefulness of fusion images of 131I SPECT and CT in patients with differentiated thyroid carcinoma.
    Yamamoto, Y
    Nishiyama, Y
    Monden, T
    Matsumura, Y
    Satoh, K
    Ohkawa, M
    JOURNAL OF NUCLEAR MEDICINE, 2002, 43 (05) : 321P - 321P
  • [48] Early outcome of I-131 ablation in differentiated thyroid cancer: 100mCi versus 150mCi
    Seo, Ye Young
    O, Joo Hyun
    Na, Sae Jung
    Kim, Sung Hoon
    Park, Young Ha
    JOURNAL OF NUCLEAR MEDICINE, 2009, 50
  • [49] FACTORS AFFECTING I-131 ABLATION OF THYROID REMNANT AFTER THYROIDECTOMY FOR DIFFERENTIATED THYROID-CANCER
    CECCARELLI, C
    MARTINO, E
    LIPPI, F
    GIANCHECCHI, D
    LUCHETTI, F
    BRACCI, E
    PINCHERA, A
    JOURNAL OF NUCLEAR MEDICINE AND ALLIED SCIENCES, 1987, 31 (01): : 46 - 46
  • [50] Ablation of the Thyroid Remnant and I-131 Dose in Differentiated Thyroid Cancer: A Meta-Analysis Revisited
    Doi, Suhail A. R.
    Woodhouse, Nicholas J.
    Thalib, Lukman
    Onitilo, Adedayo
    CLINICAL MEDICINE & RESEARCH, 2007, 5 (02) : 87 - 90
12345